ROVAC CORP
10QSB, EX-27, 2000-06-15
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ROVAC CORP, 10QSB, 2000-06-15
Next: SECURITY GROWTH & INCOME FUND/KS/, N-30D, 2000-06-15



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUL-31-1999
<PERIOD-END>                               APR-30-2000
<CASH>                                         (1,547)
<SECURITIES>                                         0
<RECEIVABLES>                                   45,154
<ALLOWANCES>                                         0
<INVENTORY>                                      3,720
<CURRENT-ASSETS>                                48,874
<PP&E>                                           6,785
<DEPRECIATION>                                 125,784
<TOTAL-ASSETS>                                 123,809
<CURRENT-LIABILITIES>                        2,653,299
<BONDS>                                              0
                                0
                                  1,200,000
<COMMON>                                       399,431
<OTHER-SE>                                 (4,128,921)
<TOTAL-LIABILITY-AND-EQUITY>                   123,809
<SALES>                                         11,941
<TOTAL-REVENUES>                                35,941
<CGS>                                           18,058
<TOTAL-COSTS>                                  129,121
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (58,066)
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (151,246)
<EPS-BASIC>                                     (0.00)
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission